Key facts
- Notable investors include Baird Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Newmarket Strategy
- ·The full record, as it builds
Funding rounds
No funding rounds for Newmarket Strategy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Newmarket Strategy
Provider of strategic advice and technical support intended to help healthcare, life sciences, and health tech providers. The company works with innovators across pharma, biotech, MedTech, diagnostics, digital health, healthcare services and infrastructure to navigate the commissioning landscape to achieve market entry, reimbursement and uptake, enabling clients to avail therapies, products and services that reach patients and clinicians.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 35
- Website
- newmarket-strategy.com/
- Ownership
- Privately Held (backing)
Newmarket Strategy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Newmarket Strategy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Newmarket Strategy in its N-PORT filings yet. We sweep new filings monthly.